Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
The current price of Merck & Co Inc in the market is 832,52 kr., with a 24-hour trading volume of 7,65B kr.. The asset's market cap is 2,05T kr., after moving -0.19% in the last day.
Tokenized Merck & Co Inc is trading at 841 kr., with a tokenized market cap of 271,69M kr. and a 24-hour trading volume of 4,52M kr.. The tokenized asset has moved 3.48% in the past 24 hours.